{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:05:14Z","timestamp":1760853914374,"version":"3.40.5"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","nucmedbio.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.nucmedbio.2016.12.009","type":"journal-article","created":{"date-parts":[[2017,1,4]],"date-time":"2017-01-04T11:15:44Z","timestamp":1483528544000},"page":"56-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["A multi species evaluation of the radiation dosimetry of [ 11 C]erlotinib, the radiolabeled analog of a clinically utilized tyrosine kinase inhibitor"],"prefix":"10.1016","volume":"47","author":[{"given":"J. Ryan","family":"Petrulli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00f8ren B.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6109-814X","authenticated-orcid":false,"given":"Galith","family":"Abourbeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maqsood","family":"Yaqub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1111-608X","authenticated-orcid":false,"given":"Idris","family":"Bahce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Holden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiyun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nabeel B.","family":"Nabulsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph N.","family":"Contessa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eyal","family":"Mishani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriaan A.","family":"Lammertsma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evan D.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2016.12.009_bb0005","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1200\/JCO.2007.14.8494","article-title":"First-line gefitinib in patients with advanced non-small-cell lung cancer harboring somatic EGFR mutations","volume":"26","author":"Sequist","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.nucmedbio.2016.12.009_bb0010","doi-asserted-by":"crossref","first-page":"S143","DOI":"10.1097\/JTO.0b013e318174e981","article-title":"First-generation epidermal growth factor receptor tyrosine kinase inhibitors in EGFR mutation: positive non-small cell lung cancer patients","volume":"3","author":"Sequist","year":"2008","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.nucmedbio.2016.12.009_bb0015","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1097\/JTO.0b013e318153fa2b","article-title":"Comparison of docetaxel- and vinca alkaloid-based chemotherapy in the first-line treatment of advanced non-small cell lung cancer: a meta-analysis of seven randomized clinical trials","volume":"2","author":"Douillard","year":"2007","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.nucmedbio.2016.12.009_bb0020","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/annonc\/mdi013","article-title":"Sequential two-line strategy for stage IV non-small-cell lung cancer: docetaxel-cisplatin versus vinorelbine-cisplatin followed by cross-over to single-agent docetaxel or vinorelbine at progression: final results of a randomised phase II study","volume":"16","author":"Douillard","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1016\/j.nucmedbio.2016.12.009_bb0025","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1054\/bjoc.2001.1784","article-title":"Combined paclitaxel and gemcitabine as first-line treatment in metastatic non-small cell lung cancer: a multicentre phase II study","volume":"84","author":"Douillard","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1016\/j.nucmedbio.2016.12.009_bb0030","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1158\/0008-5472.CAN-08-3118","article-title":"Positron emission tomography (PET) imaging with [11C]-labeled erlotinib: a micro-PET study on mice with lung tumor xenografts","volume":"69","author":"Memon","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.nucmedbio.2016.12.009_bb0035","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1593\/neo.131666","article-title":"Quantitative analysis of [11C]-erlotinib PET demonstrates specific binding for activating mutations of the EGFR kinase domain","volume":"15","author":"Petrulli","year":"2013","journal-title":"Neoplasia"},{"key":"10.1016\/j.nucmedbio.2016.12.009_bb0040","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13550-014-0080-0","article-title":"Identifying erlotinib-sensitive non-small cell lung carcinoma tumors in mice using [(11)C]erlotinib PET","volume":"5","author":"Abourbeh","year":"2015","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.nucmedbio.2016.12.009_bb0045","doi-asserted-by":"crossref","DOI":"10.2967\/jnumed.115.165225","article-title":"Quantitative and simplified analysis of 11C-erlotinib studies","author":"Yaqub","year":"2016","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2016.12.009_bb0050","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1158\/1078-0432.CCR-12-0289","article-title":"Development of [(11)C]erlotinib positron emission tomography for in vivo evaluation of EGF receptor mutational status","volume":"19","author":"Bahce","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.nucmedbio.2016.12.009_bb0055","first-page":"471","article-title":"Performance of Philips Gemini TF PET\/CT scanner with special consideration for its time-of-flight imaging capabilities","volume":"48","author":"Surti","year":"2007","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2016.12.009_bb0060","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1088\/0031-9155\/56\/8\/004","article-title":"Physical and clinical performance of the mCT time-of-flight PET\/CT scanner","volume":"56","author":"Jakoby","year":"2011","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.nucmedbio.2016.12.009_bb0065","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/00004728-199401000-00023","article-title":"The ECAT EXACT HR: performance of a new high resolution positron scanner","volume":"18","author":"Wienhard","year":"1994","journal-title":"J Comput Assist Tomogr"},{"key":"10.1016\/j.nucmedbio.2016.12.009_bb0070","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2967\/jnumed.108.055152","article-title":"Spatial resolution and sensitivity of the Inveon small-animal PET scanner","volume":"50","author":"Visser","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2016.12.009_bb0075","doi-asserted-by":"crossref","first-page":"477","DOI":"10.2967\/jnumed.108.056036","article-title":"MIRD pamphlet no. 21: a generalized schema for radiopharmaceutical dosimetry--standardization of nomenclature","volume":"50","author":"Bolch","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2016.12.009_bb0080","first-page":"1794","article-title":"Specified absorbed fractions and S-values for calculating radiation-dose from radionuclides in the gallbladder","volume":"28","author":"Stabin","year":"1987","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2016.12.009_bb0085","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/00004032-200309000-00006","article-title":"Physical models and dose factors for use in internal dose assessment","volume":"85","author":"Stabin","year":"2003","journal-title":"Health Phys"},{"key":"10.1016\/j.nucmedbio.2016.12.009_bb0090","first-page":"1023","article-title":"OLINDA\/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine","volume":"46","author":"Stabin","year":"2005","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2016.12.009_bb0095","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1124\/dmd.105.007765","article-title":"Metabolism and excretion of erlotinib, a small molecule inhibitor of epidermal growth factor receptor tyrosine kinase, in healthy male volunteers","volume":"34","author":"Ling","year":"2006","journal-title":"Drug Metab Dispos"},{"year":"2015","series-title":"Code of Federal Regulations, title 21 volume 5, document 361.1","key":"10.1016\/j.nucmedbio.2016.12.009_bb0100"},{"key":"10.1016\/j.nucmedbio.2016.12.009_bb0105","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.nucmedbio.2011.08.005","article-title":"Radiation dose estimates for carbon-11-labelled PET tracers","volume":"39","author":"van der Aart","year":"2012","journal-title":"Nucl Med Biol"},{"year":"1998","series-title":"Guidance on medical exposures in medical and biomedical research","key":"10.1016\/j.nucmedbio.2016.12.009_bb0110"},{"year":"1992","series-title":"Radiological protection in biomedical research","key":"10.1016\/j.nucmedbio.2016.12.009_bb0115"},{"year":"2016","series-title":"Human exposure to ionising radiation for clinical and research purposes: Radiation Dose & Risk Estimates","key":"10.1016\/j.nucmedbio.2016.12.009_bb0120"},{"key":"10.1016\/j.nucmedbio.2016.12.009_bb0125","series-title":"ICRP publication 103","first-page":"1","article-title":"The 2007 recommendations of the international commission on radiological protection","volume":"37","year":"2007"},{"key":"10.1016\/j.nucmedbio.2016.12.009_bb0130","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.2527\/1992.70102999x","article-title":"Genetic variation in liver mass, body mass, and liver: body mass in mice","volume":"70","author":"Jones","year":"1992","journal-title":"J Anim Sci"},{"key":"10.1016\/j.nucmedbio.2016.12.009_bb0135","first-page":"53","article-title":"Calculating the radiation dosage to an organ","volume":"14","author":"Cloutier","year":"1973","journal-title":"J Nucl Med"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805116302906?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805116302906?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T00:25:01Z","timestamp":1568679901000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805116302906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":27,"alternative-id":["S0969805116302906"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2016.12.009","relation":{},"ISSN":["0969-8051"],"issn-type":[{"type":"print","value":"0969-8051"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A multi species evaluation of the radiation dosimetry of [11C]erlotinib, the radiolabeled analog of a clinically utilized tyrosine kinase inhibitor","name":"articletitle","label":"Article Title"},{"value":"Nuclear Medicine and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2016.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}